Yi Ning Zhao
Founder at TRANSCENTA HOLDING LIMITED
Net worth: 1 M $ as of 2024-04-29
Yi Ning Zhao active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TRANSCENTA HOLDING LIMITED | Chairman | 2018-11-30 | - |
| Founder | 2018-11-30 | - | |
Veritas Genetics, Inc.
 Veritas Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Veritas Genetics, Inc. provides breast and ovarian cancer genetic testing services. It operates business through Veritas whole genome sequencing and targeted genetic testing products. The company was founded by Mirza Cifric, Preston Estep III, Joseph Thakuria, Jonathan Zhao and George MacDonald Church in 2014 and is headquartered in Danvers, MA. | Founder | 2013-12-31 | - |
| Corporate Officer/Principal | 2013-12-31 | - | |
Just - Evotec Biologics, Inc.
 Just - Evotec Biologics, Inc. Specialty StoresRetail Trade Just Biotherapeutics, Inc. operates as biotechnology firm. Its products include biosimilars and novel and repositioned biologics. The firm also offers molecular design, process and product platform and manufacturing and plant design services. The company was founded by James N. Thomas, Victor P. Fung, Dean K. Pettit, and Yining Zhao in 2014 and is headquartered in Seattle, WA. | Founder | 2013-12-31 | - |
| The BayHelix Group | Corporate Officer/Principal | 2010-12-31 | - |
| MIT Sloan School of Management | Director/Board Member | 2016-12-31 | - |
Career history of Yi Ning Zhao
Former positions of Yi Ning Zhao
| Companies | Position | Start | End |
|---|---|---|---|
Ansun Biopharma, Inc.
 Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ansun Biopharma, Inc. manufactures pharmaceutical products. Its products include Fludase, a drug candidate for the prophylaxis and treatment of respiratory infections caused by various types of influenza virus, including the types of virus that may cause a potential influenza pandemic, as well as various types of parainfluenza virus. The company was founded by Nancy Chang on August 9, 2012 and is headquartered in San Diego, CA. | Chief Operating Officer | 2020-06-30 | 2021-08-31 |
| President | 2020-06-30 | 2021-08-31 | |
| Intuition Biosciences, Inc. | Chairman | 2017-07-31 | 2021-06-30 |
| Founder | 2017-07-31 | 2021-06-30 | |
| Hangzhou Veritas Genetics, Inc. | Chief Executive Officer | 2015-04-30 | 2019-04-30 |
| Founder | 2015-04-30 | 2019-04-30 | |
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Corporate Officer/Principal | 2015-02-28 | 2018-02-28 |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
Training of Yi Ning Zhao
| Ghent University | Doctorate Degree |
| Massachusetts Institute of Technology | Masters Business Admin |
| Shanghai Medical College of Fudan University | Undergraduate Degree |
Statistics
International
| United States | 11 |
| China | 4 |
| Cayman Islands | 2 |
Operational
| Founder | 7 |
| Corporate Officer/Principal | 5 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 4 |
| Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| TRANSCENTA HOLDING LIMITED | Health Technology |
| AMGEN INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Veritas Genetics, Inc.
Veritas Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Veritas Genetics, Inc. provides breast and ovarian cancer genetic testing services. It operates business through Veritas whole genome sequencing and targeted genetic testing products. The company was founded by Mirza Cifric, Preston Estep III, Joseph Thakuria, Jonathan Zhao and George MacDonald Church in 2014 and is headquartered in Danvers, MA. | Commercial Services |
Ansun Biopharma, Inc.
Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ansun Biopharma, Inc. manufactures pharmaceutical products. Its products include Fludase, a drug candidate for the prophylaxis and treatment of respiratory infections caused by various types of influenza virus, including the types of virus that may cause a potential influenza pandemic, as well as various types of parainfluenza virus. The company was founded by Nancy Chang on August 9, 2012 and is headquartered in San Diego, CA. | Health Technology |
| Intuition Biosciences, Inc. | |
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
| The BayHelix Group | |
Just - Evotec Biologics, Inc.
Just - Evotec Biologics, Inc. Specialty StoresRetail Trade Just Biotherapeutics, Inc. operates as biotechnology firm. Its products include biosimilars and novel and repositioned biologics. The firm also offers molecular design, process and product platform and manufacturing and plant design services. The company was founded by James N. Thomas, Victor P. Fung, Dean K. Pettit, and Yining Zhao in 2014 and is headquartered in Seattle, WA. | Retail Trade |
| Hangzhou Veritas Genetics, Inc. | |
BiOneCure Therapeutics, Inc.
 BiOneCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BiOneCure Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Germantown, MD. The private company is dedicated to developing innovative antibody-based medicines for the treatment of cancer and enhancing cancer patients' lives. The company has developed proprietary payload platforms that enable a tailor-made approach for ADC drug development. The company is led by industry veterans from Pfizer, AstraZeneca, Amgen, and other similar companies with successful drug discovery and development experience in the ADC field. The company's mission is to provide first-in-class and antibody-based medicines to cancer patients with unmet medical needs. The company was founded in 2017 by Haifeng Bao and Yi Ning Zhao, and Haifeng Bao has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Yi Ning Zhao
- Experience
